Sažetak
Uvod/Cilj. Hemodijafiltracija (HDF) ima izuzetno važnu ulogu u lečenju bolesnika sa sepsom i posledičnom akutnom bubrežnom slabošću. Međutim, poremećaj krvnog pritiska (PKP) tokom HDF loše utiče na prognozu i povećava smrtnost od svih uzroka kod bolesnika sa sepsom. Cilj rada bio je da se ispitaju faktori rizika i mere prevencije PKP tokom HDF kod bolesnika sa sepsom. Metode. U ovu studiju je ukupno bilo uključeno 145 bolesnika sa sepsom koji su bili podvrgnuti HDF, i bili su podeljeni u dve grupe: grupu sa normalnim krvnim pritiskom (NKP) (n = 89) i grupu sa PKP (n = 56). Prikupljeni su njihovi klinički podaci, a nezavisni faktori uticaja na PKP tokom HDF procenjeni su univarijantnom i multivarijantnom logističkom regresionom analizom. Na osnovu rezultata multivarijantne analize konstruisan je model nomograma za predviđanje i njegova diskriminacija i konzistencija bile su procenjene korišćenjem receiver operating characteristic i cacalibration krive. Da bi se procenila prognoza 28 dana posle HDF, za crtanje krive preživljavanja korišćen je Kaplan-Majerov metod. Rezultati. Multivarijantnom logističkom regresionom analizom otkriveno je da su životno doba, kalcijum u krvi, glukoza u plazmi natašte, intaktni paratireoidni hormon, volumen ultrafiltracije i brzina ultrafiltracije bili nezavisni faktori rizika, dok je albumin bio faktor protekcije od PKP tokom HDF (p < 0,05). Model nomograma pokazao je dobar efekat uklapanja, sa visokom diskriminacijom i tačnošću. Kaplan-Majerova analiza preživljavanja pokazala je da je grupa sa NKP imala statistički značajno višu 28-dnevnu stopu preživljavanja u odnosu na grupu sa PKP (88,76% vs. 73,21%) (p < 0,05).
Zaključak. Konstruisani model rizika je pogodan za identifikaciju visokorizičnih grupa i pruža preporuku za efikasnu prevenciju i lečenje, u cilju snižavanja stope incidencije PKP i poboljšanja prognoze.
Ključne reči
Array
Array
Array
Array
Array
Array
Reference
Addissouky TA, El Tantawy El Sayed I, Ali MMA, Wang Y, El Baz A, Khalil AA, et al. Molecular Pathways in Sepsis Patho-genesis: Recent Advances and Therapeutic Avenues. J Cell Immunol 2023; 5(6): 174–83.
Rose N, Matthäus-Krämer C, Schwarzkopf D, Scherag A, Born S, Reinhart K, et al. Association between sepsis incidence and re-gional socioeconomic deprivation and health care capacity in Germany - an ecological study. BMC Public Health 2021; 21(1): 1636.
Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ 2019; 364: k4891.
Xu J. A review: continuous renal replacement therapy for sep-sis-associated acute kidney injury. All Life 2023; 16: 2163305.
Rajdev K, Leifer L, Sandhu G, Mann B, Pervaiz S, Habib S, et al. Fluid resuscitation in patients with end-stage renal disease on hemodialysis presenting with severe sepsis or septic shock: A case control study. J Crit Care 2020; 55: 157–62.
Chen Z, Sun F, Shen Y, Ma L, Liu J, Zhou Y. Impact of Dialy-sate Sodium Concentration Lowering on Home Blood Pres-sure Variability in Hemodialysis Patients. Ther Apher Dial 2019; 23(2): 153–9.
Guo L, Ji Y, Sun T, Liu Y, Jiang C, Wang G, et al. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path. Rev Cardiovasc Med 2024; 25(6): 232.
Kuipers J, Verboom LM, Ipema KJR, Paans W, Krijnen WP, Gail-lard CAJM, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with meta-analysis. Am J Nephrol 2019; 49(6): 497–506.
Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M. Hy-pertension and kidneys: unraveling complex molecular mecha-nisms underlying hypertensive renal damage. J Hum Hypertens 2014; 28(2): 74–9.
Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med 2017; 43(6): 816–28.
Hunt A. Sepsis: an overview of the signs, symptoms, diagnosis, treatment and pathophysiology. Emerg Nurse 2019; 27(5): 32–41.
Maneta E, Aivalioti E, Tual-Chalot S, Emini Veseli B, Gatsiou A, Stamatelopoulos K, et al. Endothelial dysfunction and immuno-thrombosis in sepsis. Front Immunol 2023; 14: 1144229.
Tsevi YM, Dolaama B, Tona KG, Tevi AA, Affanou EC, Amede AD, et al. Chronic renal failure and hemodialysis in Lomé: are patients on haemodialysis and their entourage well informed? Pan Afr Med J 2021; 39: 85. (French)
Latha Gullapudi VR, White K, Stewart J, Stewart P, Eldehni MT, Taal MW, et al. An analysis of frequency of continuous blood pressure variation and haemodynamic responses during hae-modialysis. Blood Purif 2022; 51(5): 435-49.
Jeong HY, Kim HJ, Han M, Seong EY, Song SH. Dialysis unit blood pressure two hours after hemodialysis is useful for pre-dicting home blood pressure and ambulatory blood pressure in maintenance hemodialysis patients. Ther Apher Dial 2022; 26(1): 103–14.
Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Di-agnosis and Management: A Review. JAMA 2019; 322(13): 1294–304.
Okpa HO, Effa EE, Oparah SK, Chikezie JA, Bisong EM, Mbu PN, et al. Intradialysis blood pressure changes among chronic kidney disease patients on maintenance haemodialysis in a ter-tiary hospital south - south Nigeria: a 2 year retrospective study. Pan Afr Med J 2019; 33: 91.
Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P. Unveiling the clinical benefits of high-volume he-modiafiltration: Optimizing the removal of medium-weight uremic toxins and beyond. Toxins 2023; 15: 531.
Tajbakhsh A, Kovanen PT, Rezaee M, Banach M, Sahebkar A. Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptot-ic Cells in Atherosclerosis. J Clin Med 2019; 8(12): 2047.
Iida M, Harada S, Takebayashi T. Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovas-cular Disease. J Atheroscler Thromb 2019; 26(9): 747-57.
Roszkowska-Blaim M, Skrzypczyk P, Jander A, Tkaczyk M, Bałasz-Chmielewska I, Żurowska A, et al. Effect of hypertension and antihypertensive medications on residual renal function in children treated with chronic peritoneal dialysis. Adv Med Sci 2015; 60(1): 18–24.
Zhou X, Guo Y, Luo Y. The optimal range of serum intact par-athyroid hormone for a lower risk of mortality in the incident hemodialysis patients. Ren Fail 2021; 43(1): 599–605.
Kim TW, Chang TI, Kim TH, Chou JA, Soohoo M, Ravel VA, et al. Association of ultrafiltration rate with mortality in incident hemodialysis patients. Nephron 2018; 139(1): 13–22.